English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

This study was designed to assess if low dose lidocaine (L) (0.8 mg/min at a constant rate infusion following a 100 mg bolus) combined with magnesium sulfate (M) (2.5 mg/min) controlled warning ventricular arrhythmias (a total of 119,806 ectopic beats and 146 runs of sustained ventricular tachycardia) in 7 (17%) out of 41 patients undergoing ambulatory monitoring. L alone was administered during the first 48 hours, then L+M for 48 hours, followed by L alone for a further 48 hours. Every 12 hours L serum levels were measured. Serum levels of L alone ranged from 0.33 to 2.06 mg/l (mean: 1.28 +/- 0.7 mg/l) during the first 48 hours and from 0.30 to 2.96 mg/l (mean: 1.24 +/- 1.02 during the last 48 hours). When the subjects received L+M, L serum levels were 0.69 to 3.28 mg/l (mean: 1.60 +/- 0.9 with p less than 0.05, statistically significant). Ambulatory monitoring also displayed a 70% reduction in warning ventricular arrhythmias during L+M treatment. L+M are more effective in the control of warning ventricular arrhythmias and we can also administer a lower dose of lidocaine when given in combination.

Low Dose Lidocaine Combined with Magnesium Sulfate in Warning Ventricular Arrhythmias.